Experimental fusion of the sheep cervical spine. Part II: Effect of growth factors and carrier systems on interbody fusion;Experimentelle Spondylodese der Schafshalswirbelsäule: Teil 2: Der Effekt von Wachstumsfaktoren und Carrier-Systemen auf die intervertebrale Fusion

Chirurg

Volumn 73, Issue 10, 2002, Pages 1025-1038

  Kandziora, F ^a   Scholz, M ^a   Pflugmacher, R ^a   Krummrey, G ^a   Schollmeier, G ^a   Schmidmaier, G ^a   Schnake, K J ^a   Duda, G ^a   Raschke, M ^a   Haas, N P ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Animal model; Biodegradable; BMP 2; Cervical spine; Coating of implants; Growth factor; IGF I; Interbody fusion; PDLLA; Sheep; TGF 1

Indexed keywords

BIOMATERIAL; BONE MORPHOGENETIC PROTEIN; BONE MORPHOGENETIC PROTEIN 2; COLLAGEN; DRUG CARRIER; POLYESTER; POLYLACTIDE; SOMATOMEDIN C; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA1;

ANIMAL; ARTICLE; BIOMECHANICS; BONE DENSITY; BONE MATRIX; CERVICAL SPINE; COMPARATIVE STUDY; COMPUTER ASSISTED TOMOGRAPHY; DRUG EFFECT; ELASTICITY; FEMALE; METHODOLOGY; PATHOLOGY; PROSTHESES AND ORTHOSES; SHEEP; SPINE FUSION;

ANIMALS; BIOMECHANICS; BONE DENSITY; BONE MATRIX; BONE MORPHOGENETIC PROTEINS; CERVICAL VERTEBRAE; COATED MATERIALS, BIOCOMPATIBLE; COLLAGEN; DRUG CARRIERS; ELASTICITY; FEMALE; INSULIN-LIKE GROWTH FACTOR I; POLYESTERS; PROSTHESES AND IMPLANTS; SHEEP; SPINAL FUSION; TOMOGRAPHY, X-RAY COMPUTED; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA1;

EID: 18744369024     PISSN: 00094722     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00104-002-0490-9     Document Type: Article

References (64)

1. Ammann P, Bourrin S, Bonjour JP, Meyer JM, Rizzoli R (2000) Protein under-nutrition-induced bone loss is associated with decreased IGF-I levels and oestrogen deficiency. J Bone Miner Res 15:683-669
2. Aspenberg P, Turek T (1996) BMP-2 for intramuscular bone induction. Effect of squirrel monkeys is dependent on implantation site. Acta Orthop Scand 67:3-6
3. Beck L, Amento E, Xu Y, Deguzman L, Lee W, Nguyen T, Gillet N (1993) TGF-beta 1 induces bone closure of skull defects - temporal dynamics of bone formation in defects exposed to rhTGF-beta 1. J Bone Miner Res 8:753-761
4. Boden SD, Martin GJ Jr, Horton WC, Truss TL, Sandhu HS (1998) Laproscopic anterior spinal arthrodesis with rh BMP-2 in a titanium interbody threaded cage. J Spinal Disord 11:95-101
5. Boden SD, Martin GJ Jr, Morone MA, Ugbo JL, Moskovitz PA (1999) Posterolateral lumbar intertransverse process spine arthrodesis with recombinant human bone morphogenetic protein 2/hydroxyapatite-tricalcium phosphate after laminectomy in the nonhuman primate. Spine 24:1179-1185
6. Boden SD, Zdeblick TA, Sandhu HS, Heim SE (2000) The use of rhBMP-2 in interbody fusion cages. Definitive evidence of osteoinduction in humans: a preliminary report. Spine 25:376-381
7. Brady JM, Cutright DE, Miller RA, Barristone GC (1973) Resorption rate, route, route of elimination, and ultrastructure of the implant size of polylactic acid in the abdominal wall of the rat. J Biomed Mater Res 7:155-166
8. Cutright DE, Hunsuck EE, Beasley JD (1971) Fracture reduction using a biodegradable material, polylactic acid. J Oral Surg 29:393-397
9. David SM, Gruber HE, Mayer RA Jr et al. (1999) Lumbar spinal fusion using recombinant human bone morphogenetic protein in the canine. A comparison of three dosages and two carriers. Spine 24:1973-1979
10. Fischgrund JS, James SB, Chabot MC, Hankin R, Herkowitz HN, Wozney JM, Shirkhoda A (1997) Augmentation of autograft using rhBMP-2 and different carrier media in the canine spinal fusion model. J Spinal Disord 10:467-472
11. Fujimoto A, Tanizawa T, Nishida S, Yamamoto N, Soshi S, Endo N, Takahashi HE (1999) Local effects of transforming growth factor-beta 1 on rat calvaria: changes depending on the dose and the injection site. J Bone Miner Metab 17:11-17
12. Gombotz W, Pankey S, Bouchard L, Ranchalis J, Puolakkainen P (1993) Controlled release of TGF-beta 1 from a biodegradable matrix for bone regeneration. J Biomater Sci Polym Ed 5:49-63
13. Gopferich A (1996) Mechanisms of polymer degradation and erosion. Biomaterials 17:103-114
14. Grauer JN, Patel TC, Erulkar JS, Troiano NW, Panjabi MM, Friedlaender GE (2001) 2000 Young Investigator Research Award winner. Evaluation of OP-1 as a graft substitute for intertransverse process lumbar fusion. Spine 26:127-133
15. Hecht BP, Fischgrund JS, Herkowitz HN, Penman L, Toth JM, Shirkhoda A (1999) The use of recombinant human bone morphogenetic protein 2 (rhBMP-2) to promote spinal fusion in a nonhuman primate anterior interbody fusion model. Spine 24:629-636
16. Hermann R, Schmidmaier G, Markl B, Resch A, Hahnel I, Stemberger A, Alt E (1999) Antithrombogenic coating of stents using a biodegradable drug delivery technology. Thromb Haemost 82:51-57
17. Hock J, Centrella M, Canalis E (1988) Insulin like growth factor 1 has independent effects on bone matrix formation and cell replication. Endocrinology 122:254-260
18. Hollinger JO, Battistone GC (1988) Biodegradable bone repair materials. Synthetic polymers and ceramics. Clin Orthop 278:290-305
19. Hoshi K, Amizuka N, Sakou T, Kurokawa T, Ozawa H (1997) Fibroblasts of spinal ligaments pathologically differentiate into chondrocytes induced by recombinant human bone morphogenetic protein-2:morphological examinations for ossification of spinal ligaments. Bone 21:155-162
20. Hutmacher D, Hurzeler MB, Schliephacke H (1996) A review of material properties of biodegradable and bioresorbable polymers and devices for GTR and GBR applications. Int J Oral Maxillofac Implants 11:667-678
21. Isgaard J, Nilson A, Lindahl A, Jansson J, Isaksson O (1986) Effects of local administration of GH and IGF-I on longitudinal bone growth in rats. Am J Physiol 250:367-372
22. Itoh H, Ebara S, Kamimura M, Tateiwa Y, Kinoshita T, Yuzawa Y, Takaoka K (1999). Experimental spinal fusion with use of recombinant human bone morphogenetic protein 2. Spine 24:1402-1405
23. Kandziora F, Kerschbaumer F, Starker M, Mittlmeier T (2000). Biomechanical assessment of transoral plate fixation for atlantoaxial instability. Spine 25:1555-1561
24. Kandziora F, Pflugmacher R, Scholz M, Schnake K, Schröder R, Mittlmeier T (2001) Comparison between sheep and human cervical spines: an anatomic, radiographic, bone mineral density, and biomechanical study. Spine 26:1028-1037
25. Kandziora F, Pflugmacher R, Schäfer J, Duda G, Haas NP, Mittlmeier T (2001) Biomechanical comparison of cervical spine interbody fusion cages. Spine 26:1850-1857
26. Kandziora F, Schmidmaier G, Schollmeier G, Bail H, Pflugmacher R, Görke T, Wagner M, Raschke M, Mittlmeier T, Haas NP (in press) IGF-I and TGF-β1 application by a poly-(D,L-lactide) coated interbody cage promotes fusion in the sheep cervical spine. Spine 27
27. Kandziora F, Pflugmacher R, Scholz M et al. (eingereicht) Experimentelle Spondylodese der Schafshalswirbelsäule. Teil 1: Der Effekt des Cagedesigns auf die intervertebrale Fusion. Der Chiurg
28. Kleemann R (1999) Entwicklung eines Wirbelsäulenprüfstands zur Testung von Implantaten an der Halswirbelsäule; Semesterarbeit. Fakultät für Maschinenbau. Technische Universität Berlin
29. Kon T, Yamazaki M, Tagawa M, Goto S, Terakado A, Moriya H, Fujimura S (1997) Bone morphogenetic protei-2 stimulates differentiation of cultured spinal ligament cells from patients with ossification of the posterior longitudinal ligament. Calcif Tissue Int 60:291-296
30. Kulkarni RK, Moore EG, Hegyeli AF, Leonard F (1971) Biodegradable poly(lactic acid) polymers. J Biomed Mater Res 5:169-181
31. Kulkarni RK, Pani KC, Neuman C, Leonard F (1966) Polylactic acid for surgical implants. Arch Surg 93:839-843
32. Kumta SM, Spinner R, Leung PC (1992) Absorbable intramedullary implants for hand fractures. Animal experiment and clinical trial. J Bone Joint Surg Br 93:839-843
33. Laurencin C, Lane JM (1994) Poly (lactide acid) and Poly (glycolid acid): orthopedic surgery applications. In: Brighton C, Frielaender G, Lane MJ (eds) Bone formation and repair. American Academy of Orthopedic Surgeons, Rosemont, pp 325-339
34. Laursen M, Hoy K, Hansen ES, Gelineck J, Christensen FB, Bunger CE (1999) Recombinant bone morphogenetic protein-7 as an intracorporal bone growth stimulator in unstable thoracolumbar burst fractures in humans: preliminary results. Eur Spine J 8:485-490
35. Lind M (1998) Growth factor stimulation on bone healing (1998) Effects on osteoblasts, osteotomies, and implants fixations. Acta Orthop Scand [Suppl] 283:2-37
36. Lind M, Schuhmacker B, Soballe K, Keller J, Melson F, Bunger C (1993) Transforming growth factor-beta enhances fracture healing in rabbit tibiae. Act Orthop Scand 64:553-556
37. Majola A, Vainionpaa S, Vihtonen K, Mero M, Vasenius J, Tormala P, Rokkanen P (1991) Absorption, biocompatibility and fixation properties of polylactic acid in bone tissue: an experimental study in rats. Clin Orthop 244:260-269
38. Martin GJ Jr, Boden SD, Marone MA, Marone MA, Moskovitz PA (1999) Posterolateral intertransverse process spinal arthrodesis with rhBMP-2 in a nonhuman primate: important lessons learned regarding dose, carrier, and safety. J Spinal Disord 12:179-186
39. Meyer RA Jr, Gruber HE, Howard BA et al. (1999) Safety of recombinant human bone morphogenetic protein-2 after spinal laminectomy in the dog. Spine 24:747-754
40. Miller RA, Brady JM, Cutright DE (1977) Degradation rates of oral resorbable implants (polylactates and polyglycolates): rate modification with changes in PLA/PGA copolymer ratios. J Biomed Mater Res 11:711-719
41. Mimatsu K, Kishi S, Hashizume Y (1997) Experimental chronic compression on the spinal cord of the rabbit by ectopic bone formation in the ligamantum flavum with bone morphogenetic protein. Spinal Cord 35:740-746
42. Mohan S, Baylink D (1991) Bone growth factors. Clin Orthop Rel Res 263:30-48
43. Nielson H, Isgaard J, Lindahl A, Peterson L, Isaksson O (1987) Effects of unilateral arterial infusion of GH and IGF-I on tibial longitudinal bone growth in hypophysectomized rats. Calcif Tissue Int 40:91-96
44. Ozuna R, Sandhu HS, Kanim LEA (1995) Carriers of bone morphogenetic protein for posterolateral spinal fusion. Proceedings of the North American Spine Society 10th Annual Meeting, p 14
45. Pfeilschifter J, Oechsner M, Naumann A, Gronwald R, Minne H ,Ziegler R (1990) Stimulation of bone matrix apposition in vitro by local growth factors: a comparison between insulin-like growth factor I, platelet derived growth factor and transforming growth factor beta. Endocrinology 127:69-75
46. Roberts A, Sporn M, Bolander M (1990) Transforming growth factor-beta and the initiation of chondrogenesis in the rat femur. J Cell Biol 110:2195-2207
47. Saitoh H, Takata T, Nikai H, Shintani H, Hyon SH, Ikada Y (1994) Effect of polylactic acid on osteoinduction of demineralized bone: preliminary study of the usefulness of polylactic acid as a carrier of bone morphogenetic protein. J Oral Rehabil 21:431-438
48. Sandhu HS, Kanim LE, Kabo JM et al. (1996) Effective doses of recombinant human bone morphogenetic protein-2 in experimental spinal fusion. Spine 21:2115-2122
49. Sandhu HS, Kanim LE, Toth JM, Kabo Jm, Liu D, Delamarter RB, Dawson EG (1997) Experimental spinal fusion with recombinant human bone morphogenetic protein-2 without decortication of osseous elements. Spine 22:1171-1180
50. Schmidmaier G, Wildemann B, Stemberger A, Haas NP, Raschke M (2001) Biodegradable poly-(D,L-lactide) coating of implants for contionous release of growth factors. J Biomed Mat Res 58:449-455
51. Schmidmaier G, Wildemann B, Stemberger A, Haas NP, Raschke M (2001) Local application of growth factors (insulin-like growth factor-1 and transforming growth factor-beta1) from a biodegradable poly(D,L-lactide) coating of osteosynthetic implants accelerates fracture healing in rats. Bone 28:341-350
52. Slappey G, Toribatake Y, Ganey TM, Odgen JA, Hutton WC (1998) Guidelines to decortication in posterolateral spine fusion. J Spinal Disord 11:102-109
53. Sorensen TS, Sorensen AI, Merser S (1990) Rapid release of gentamicin from collagen sponge. In vitro comparison with plastic beads. Acta Orthop Scand 61:353-356
54. Steinbrech DS, Mehrara BJ, Rowe NM et al. (2000). Gene expression of TGF-beta, TGF-beta receptor, and extracellular matrix proteins during membranous bone healing in rats. Plast Reconstr Surg 105:2028-2038
55. Takaoka K, Koezuka M, Nakahara H (1991) Telepeptide-depleted bovine skin collagen as a carrier for bone morphogenetic protein. J Orthop Res 9:902-907
56. Tamada JA, Langer R (1993) Erosion kinetics of hydrolytically degradable polymers. Proc Natl Acad Sci USA 90:552-556
57. Terrell TG, Working PK, Chow CP, Green JD (1993) Pathology of recombinant human transforming growth factor-beta 1. in rats and rabbits. Int Rev Exp Pathol 34B:43-67
58. Thaller S, Hoyt J, Tesluck H, Holmes R (1993) The effect of insulin growth factor - I on calvarial sutures in Sprague-Dawley rat. J Craniofac Surg 4:35-39
59. Trippel S, Coutts R, Einhorn T, Mundy R, Rosenfeld R (1996) Growth factors as therapeutic agents. J Bone Joint Surg 78A:1272-1286
60. Urist MR (1965) Bone: formation by autoinduction. Science 150:893-899
61. Wilton P (1992) Treatment with recombinant human insulin-like growth factor I of children with growth hormone receptor deficiency (Laron syndrome). Kabi Pharmacia Study Group on insulin-like growth factor I treatment in growth hormone insensitivity syndromes. Acta Paediatr Suppl 383:137-142
62. Yamada Y, Harada A, Hosoi T, Miyauchi A, Ikeda K, Otha H, Shiraki M (2000) Association of transforming growth factor beta 1 genotype with therapeutic response to active vitamin D for postmenopausal osteoporosis. J Bone Miner Res 15:415-420
63. Zdeblick TS, Ganayem AJ, Rapoff AJ, Swain C, Bassett T, Cooke ME, Markel M (1998) Cervical interbody fusion cages. An animal model with and without bone morphogenetic protein. Spine 23:758-765
64. Zegzula HD, Buck DC, Brekke J, Wozney JM, Hollinger JO (1997) Bone formation with use of rhBMP-2 (recombinant human bone morphogenetic protein-2). J Bone Joint Surg Am 79:1778-1790